OXYCODONE and ACETAMINOPHEN, USP 10 mg/325 mg, CII, 100 TABLETS, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-4982-21
Published September 10, 2014 · Recall initiated: August 27, 2014
Summary
FDA records drug Class II recall D-1572-2014, published September 10, 2014 and initiated August 27, 2014. Recalling firm: Qualitest Pharmaceuticals; Status: Terminated; Reported quantity: 23,544 bottles; Lot: T062A14A, Exp 12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Broken tablets found in sealed bottles.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Qualitest Pharmaceuticals
- Distributor
- Nationwide
- Lot
- T062A14A, Exp 12/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAALLOPURINOL TABLETS, USP, 300 mg, 500 count bottle, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS,September 9, 2015
- FDAHydrOXYzine Hydrochloride Tablets, USP 25 mg, Rx only, 100 count (NDC 0603-3968-21), 500 count (NDCJuly 22, 2015
- FDADisulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qualitest PharmaceuticalsJuly 8, 2015
- FDAPROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml contains: Codeine Phosphate 10 mg, Promethazine HydrochlorideApril 15, 2015
- FDAComfort Shield Barrier Cream Cloths with dimethicone a) 8 count NDC 53462-915-80, b) 24 count NDCSeptember 10, 2014
- FDAVerigene CYP2C19 Nucleic Acid Test (CYP2C19 Test). Each CYP2C19 kit consists of 20 Verigene CYP2C19 NucleicSeptember 3, 2014
Questions about this recall
Was OXYCODONE and ACETAMINOPHEN, USP 10 mg/325 mg, CII, 100 TABLETS, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-4982-21 recalled?
Yes. FDA published recall D-1572-2014 on September 10, 2014. Reported hazard: Failed Tablet/Capsule Specifications: Broken tablets found in sealed bottles.
What should I do if I have this product?
Voluntary: Firm initiated · Letter